High molecular weight amyloid β_1-42 oligomers induce neurotoxicity via plasma membrane damage

Area of Science:

• Neuroscience
• Biochemistry
• Pathology

Background:

• Amyloid-beta (Aβ) aggregation into oligomers and fibrils is central to Alzheimer's disease (AD) pathology.
• While amyloid plaques are a hallmark of AD, therapies targeting them have shown limited clinical success.
• Emerging evidence suggests soluble amyloid oligomers, particularly high molecular weight (HMW) species, are key drivers of neurotoxicity.

Purpose of the Study:

• To investigate the specific mechanisms by which HMW amyloid-beta (Aβ) oligomers induce neuronal dysfunction.
• To compare the neurotoxic effects of HMW-Aβ oligomers versus low molecular weight (LMW) Aβ oligomers.
• To assess the potential of targeting HMW-Aβ oligomers for AD therapeutic strategies.

Main Methods:

• Exposure of neurons to HMW-Aβ1-42 oligomers.
• Measurement of membrane integrity, reactive oxygen species (ROS) generation, and lipid peroxidation.
• Assessment of membrane fluidity, intracellular calcium levels, membrane potential, and long-term potentiation (LTP).

Main Results:

• HMW-Aβ1-42 significantly impaired neuronal membrane integrity.
• Exposure induced ROS generation and lipid peroxidation, leading to reduced membrane fluidity.
• HMW-Aβ1-42 caused intracellular calcium dysregulation, membrane depolarization, and impaired LTP, with effects more pronounced than LMW-Aβ1-42.

Conclusions:

• HMW-Aβ1-42 oligomers directly damage neuronal plasma membranes through oxidative stress and lipid peroxidation.
• This membrane damage disrupts crucial neuronal functions, including calcium homeostasis and synaptic plasticity.
• Targeting and reducing HMW-Aβ oligomers represents a promising therapeutic approach to mitigate neurodegeneration in Alzheimer's disease.